The sale is routine and part of a pre-arranged plan, not an isolated event. Traders should monitor for further sales under this plan, but the current filing alone does not signal material concern. However, the cumulative insider selling over $14.6M in one month may warrant attention if it continues.
Price Chart
Executive Summary
Jeremy Chadwick, an officer of Kymera Therapeutics, filed a Form 144 to notify the SEC of his intent to sell 1,300 shares of common stock, representing a small portion of his holdings. This is part of a broader 10b5-1 trading plan, following a series of prior sales totaling over $14.6M in the past month.
Key Facts
- Jeremy Chadwick, an officer of Kymera Therapeutics, filed Form 144 to propose selling 1,300 shares.
- The shares are common stock, to be sold on or after April 15, 2026, via Morgan Stanley Smith Barney LLC.
- This filing is part of an existing 10b5-1 plan, with recent sales by Chadwick totaling approximately $14.6 million over the past month.
- The proposed sale is relatively small compared to prior transactions and the company's $7.3B market cap.
Financial Impact
Approximately $116,824.50 (based on $89.86/share), representing a minimal portion of recent insider selling activity
Risk Factors
- Perception of insider confidence if selling persists under 10b5-1 plan amid no fundamental updates
- Potential for increased share supply if larger blocks are sold in coming periods
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003490 |
| Document: 0001950047-26-003490-index.html | 0001950047-26-003490 |
| Document: 0001950047-26-003490.txt | 0001950047-26-003490 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $105.48 $118.63 | ▲ +12.47% | ▲ +13.07% | $107.39 (+1.81%) |
Jul 8, 2026 12w ago | Insider Cluster | $114.16 $105.48 | ▲ +7.60% | ▲ +10.88% | $107.39 (+5.93%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jul 2, 2026 13w ago | Insider Cluster | $113.51 $107.01 | ▲ +5.73% | ▲ +5.31% | $107.39 (+5.39%) |
Jun 30, 2026 13w ago | 144 | $114.20 $105.25 | ▲ +7.84% | ▲ +5.65% | $107.39 (+5.96%) |
Jun 29, 2026 13w ago | 144 | $114.67 $110.05 | ▼ −4.03% | ▼ −3.00% | $107.39 (−6.35%) |
Jun 26, 2026 13w ago | Insider Cluster | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 13w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 26, 2026 14w ago | 144 | $109.32 $110.57 | ▼ −1.14% | ▼ −1.42% | $107.39 (+1.77%) |
Jun 24, 2026 14w ago | 144 | $116.46 $110.38 | ▼ −5.22% | ▼ −5.75% | $107.39 (−7.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access